Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+ T cell interleukin-2 secretion
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+ T cell interleukin-2 secretion
Authors
Keywords
-
Journal
mAbs
Volume 15, Issue 1, Pages -
Publisher
Informa UK Limited
Online
2023-09-08
DOI
10.1080/19420862.2023.2253570
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a FRET-Based Assay for Analysis of mAbs Internalization and Processing by Dendritic Cells in Preclinical Immunogenicity Risk Assessment
- (2020) Yi Wen et al. AAPS Journal
- T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020
- (2020) Vibha Jawa et al. Frontiers in Immunology
- Targeted inhibition of sclerostin for post-menopausal osteoporosis therapy: A critical assessment of the mechanism of action
- (2018) Sharmistha Bhattacharyya et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MAPPs for the identification of immunogenic hotspots of biotherapeutics; an overview of the technology and its application to the biopharmaceutical arena
- (2018) Valerie Quarmby et al. Expert Review of Proteomics
- MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicity
- (2018) Nobuo Sekiguchi et al. mAbs
- Immunogenicity assessment during the development of protein therapeutics
- (2017) Amy S. Rosenberg et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- The making of bispecific antibodies
- (2017) Ulrich Brinkmann et al. mAbs
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emicizumab Prophylaxis in Hemophilia A with Inhibitors
- (2017) Johannes Oldenburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay
- (2017) Heidi S. Schultz et al. PLoS One
- Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study
- (2016) Luc Chouinard et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins
- (2016) Alison Smith et al. Journal of Immunology Research
- Immunogenicity to Biotherapeutics – The Role of Anti-drug Immune Complexes
- (2016) Murli Krishna et al. Frontiers in Immunology
- Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics
- (2016) Marisa K. Joubert et al. PLoS One
- A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
- (2015) Robert R. Recker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Alternative molecular formats and therapeutic applications for bispecific antibodies
- (2015) Christoph Spiess et al. MOLECULAR IMMUNOLOGY
- Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity
- (2013) Zenjiro Sampei et al. PLoS One
- Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients
- (2012) S. F. J. Whelan et al. BLOOD
- Measurement of Anti-Erythropoiesis-Stimulating Agent IgG4 Antibody as an Indicator of Antibody-Mediated Pure Red Cell Aplasia
- (2012) Dohan K. Weeraratne et al. Clinical and Vaccine Immunology
- A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
- (2012) Takehisa Kitazawa et al. NATURE MEDICINE
- IgG4-Related Disease
- (2012) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors
- (2011) Stephanie Delluc et al. FASEB JOURNAL
- A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy
- (2011) Simone C Wuest et al. NATURE MEDICINE
- Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics
- (2010) Danika Wullner et al. CLINICAL IMMUNOLOGY
- Impact of Product-Related Factors on Immunogenicity of Biotherapeutics
- (2010) Satish Kumar Singh JOURNAL OF PHARMACEUTICAL SCIENCES
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- A signature-based method for indexing cell cycle phase distribution from microarray profiles
- (2009) Hideaki Mizuno et al. BMC GENOMICS
- Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
- (2009) Zehra Kaymakcalan et al. CLINICAL IMMUNOLOGY
- Human naive and memory CD4+T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells
- (2009) Rebekka Geiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Optimization of a dendritic cell-based assay for the in vitro priming of naïve human CD4+ T cells
- (2009) Janice M. Moser et al. JOURNAL OF IMMUNOLOGICAL METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started